AKAPs: The architectural underpinnings of local cAMP signaling

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 351-358

  Kritzer, Michael D ^a   Li, Jinliang ^a   Dodge Kafka, Kimberly ^b   Kapiloff, Michael S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

AKAP; CAMP; Compartmentation; PKA; Scaffold; Signaling

Indexed keywords

CALCINEURIN; CALCIUM CHANNEL L TYPE; CALCIUM ION; CARRIER PROTEINS AND BINDING PROTEINS; CAVEOLIN 3; CONNECTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 13; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 18; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 6; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 79; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 9; HISTONE DEACETYLASE 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; PHOSPHOLAMBAN; POLYCYSTIN 1; PROTEIN 14 3 3; PROTEIN BCL 2; PROTEIN KINASE C; RAP1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RYANODINE RECEPTOR 2; TROPONIN I; UNCLASSIFIED DRUG;

APOPTOSIS; CALCIUM TRANSPORT; CARDIOMYOPATHY; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HUMAN; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SARCOMERE; SECOND MESSENGER; SIGNAL TRANSDUCTION;

A KINASE ANCHOR PROTEINS; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MYOCYTES, CARDIAC; PROTEIN BINDING; SARCOMERES; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 84855998675     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.05.002     Document Type: Review

References (109)

1. Conti M., Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 2007, 76:481-511.
2. Sadana R., Dessauer C.W. Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals 2009, 17(1):5-22.
3. Hayes J.S., Brunton L.L., Mayer S.E. Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1. J Biol Chem 1980, 255(11):5113-5119.
4. Keely S.L. Activation of cAMP-dependent protein kinase without a corresponding increase in phosphorylase activity. Res Commun Chem Pathol Pharmacol 1977, 18(2):283-290.
5. Hayes J.S., Brunton L.L., Brown J.H., Reese J.B., Mayer S.E. Hormonally specific expression of cardiac protein kinase activity. Proc Natl Acad Sci U S A 1979 Apr, 76(4):1570-1574.
6. Jarnaess E., Tasken K. Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans 2007 Nov, 35(Pt 5):931-937.
7. Smith F.D., Langeberg L.K., Scott J.D. The where's and when's of kinase anchoring. Trends Biochem Sci 2006 Jun, 31(6):316-323.
8. Carnegie G.K., Means C.K., Scott J.D. A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 2009 Apr, 61(4):394-406.
9. Efendiev R., Samelson B.K., Nguyen B.T., Phatarpekar P.V., Baameur F., Scott J.D., et al. AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC5 and -6 to alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors. J Biol Chem 2010 May 7, 285(19):14450-14458.
10. Dodge-Kafka K.L., Soughayer J., Pare G.C., Carlisle Michel J.J., Langeberg L.K., Kapiloff M.S., et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005 Sep 22, 437(7058):574-578.
11. Zaccolo M. Phosphodiesterases and compartmentalized cAMP signalling in the heart. Eur J Cell Biol 2006 Jul, 85(7):693-697.
12. Zaccolo M. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies. Br J Pharmacol 2009 Sep, 158(1):50-60.
13. Jurevicius J., Fischmeister R. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. Proc Natl Acad Sci U S A 1996, 93(1):295-299.
14. Rochais F., Abi-Gerges A., Horner K., Lefebvre F., Cooper D.M., Conti M., et al. A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes. Circ Res 2006 Apr 28, 98(8):1081-1088.
15. Mongillo M., McSorley T., Evellin S., Sood A., Lissandron V., Terrin A., et al. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ Res 2004 Jul 9, 95(1):67-75.
16. Houslay M.D., Baillie G.S., Maurice D.H. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ Res 2007 Apr 13, 100(7):950-966.
17. Nikolaev V.O., Bunemann M., Schmitteckert E., Lohse M.J., Engelhardt S. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. Circ Res 2006 Nov 10, 99(10):1084-1091.
18. Nikolaev V.O., Moshkov A., Lyon A.R., Miragoli M., Novak P., Paur H., et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010 Mar 26, 327(5973):1653-1657.
19. Scott J.D. Cyclic nucleotide-dependent protein kinases. Pharmacol Ther 1991, 50(1):123-145.
20. Di Benedetto G., Zoccarato A., Lissandron V., Terrin A., Li X., Houslay M.D., et al. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 2008 Oct 10, 103(8):836-844.
21. Corbin J.D., Sugden P.H., Lincoln T.M., Keely S.L. Compartmentalization of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in heart tissue. J Biol Chem 1977, 252(11):3854-3861.
22. Buxton I.L., Brunton L.L. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 1983, 258(17):10233-10239.
23. Tovey S.C., Dedos S.G., Taylor E.J., Church J.E., Taylor C.W. Selective coupling of type 6 adenylyl cyclase with type 2 IP3 receptors mediates direct sensitization of IP3 receptors by cAMP. J Cell Biol 2008 Oct 20, 183(2):297-311.
24. Dessauer C.W. Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 2009 Nov, 76(5):935-941.
25. Escobar M., Cardenas C., Colavita K., Petrenko N.B., Franzini-Armstrong C. Structural evidence for perinuclear calcium microdomains in cardiac myocytes. J Mol Cell Cardiol 2011 Mar, 50(3):451-459.
26. Kapiloff M.S., Piggott L.A., Sadana R., Li J., Heredia L.A., Henson E., et al. An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes. J Biol Chem 2009 Aug 28, 284(35):23540-23546.
27. Defer N., Best-Belpomme M., Hanoune J. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol 2000 Sep, 279(3):F400-F416.
28. Willoughby D., Cooper D.M. Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev 2007 Jul, 87(3):965-1010.
29. Tang T., Lai N.C., Hammond H.K., Roth D.M., Yang Y., Guo T., et al. Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice. J Am Coll Cardiol 2010 Apr 6, 55(14):1476-1486.
30. Okumura S., Takagi G., Kawabe J., Yang G., Lee M.C., Hong C., et al. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A 2003 Aug 19, 100(17):9986-9990.
31. Nichols C.B., Rossow C.F., Navedo M.F., Westenbroek R.E., Catterall W.A., Santana L.F., et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res 2010 Sep 17, 107(6):747-756.
32. Taylor S.S., Kim C., Cheng C.Y., Brown S.H., Wu J., Kannan N. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochim Biophys Acta 2008 Jan, 1784(1):16-26.
33. Sarma G.N., Kinderman F.S., Kim C., von Daake S., Chen L., Wang B.C., et al. Structure of D-AKAP2:PKA RI complex: insights into AKAP specificity and selectivity. Structure 2010 Feb 10, 18(2):155-166.
34. Newlon M.G., Roy M., Morikis D., Hausken Z.E., Coghlan V., Scott J.D., et al. The molecular basis for protein kinase A anchoring revealed by solution NMR. Nat Struct Biol 1999, 6(3):222-227.
35. Banky P., Roy M., Newlon M.G., Morikis D., Haste N.M., Taylor S.S., et al. Related protein-protein interaction modules present drastically different surface topographies despite a conserved helical platform. J Mol Biol 2003 Jul 25, 330(5):1117-1129.
36. Gold M.G., Lygren B., Dokurno P., Hoshi N., McConnachie G., Tasken K., et al. Molecular basis of AKAP specificity for PKA regulatory subunits. Mol Cell 2006 Nov 3, 24(3):383-395.
37. Carlson C.R., Lygren B., Berge T., Hoshi N., Wong W., Tasken K., et al. Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J Biol Chem 2006 Jul 28, 281(30):21535-21545.
38. Torheim E.A., Jarnaess E., Lygren B., Tasken K. Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling. Biochem J 2009 Nov 15, 424(1):69-78.
39. Fink M.A., Zakhary D.R., Mackey J.A., Desnoyer R.W., Apperson-Hansen C., Damron D.S., et al. AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes. Circ Res 2001 Feb 16, 88(3):291-297.
40. McConnell B.K., Popovic Z., Mal N., Lee K., Bautista J., Forudi F., et al. Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J Biol Chem 2009 Jan 16, 284(3):1583-1592.
41. Patel H.H., Hamuro L.L., Chun B.J., Kawaraguchi Y., Quick A., Rebolledo B., et al. Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function. J Biol Chem 2010 Sep 3, 285(36):27632-27640.
42. Carr D.W., Stofko-Hahn R.E., Fraser I.D., Cone R.D., Scott J.D. Localization of the cAMP-dependent protein kinase to the postsynaptic densities by A-kinase anchoring proteins. Characterization of AKAP 79. J Biol Chem 1992, 267(24):16816-16823.
43. Dell'Acqua M.L., Faux M.C., Thorburn J., Thorburn A., Scott J.D. Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4, 5-bisphosphate. EMBO J 1998, 17(8):2246-2260.
44. Tunquist B.J., Hoshi N., Guire E.S., Zhang F., Mullendorff K., Langeberg L.K., et al. Loss of AKAP150 perturbs distinct neuronal processes in mice. Proc Natl Acad Sci U S A 2008 Aug 26, 105(34):12557-12562.
45. Weisenhaus M., Allen M.L., Yang L., Lu Y., Nichols C.B., Su T., et al. Mutations in AKAP5 disrupt dendritic signaling complexes and lead to electrophysiological and behavioral phenotypes in mice. PLoS One 2010, 5(4):e10325.
46. Fraser I.D., Cong M., Kim J., Rollins E.N., Daaka Y., Lefkowitz R.J., et al. Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol 2000, 10(7):409-412.
47. Gardner L.A., Tavalin S.J., Goehring A.S., Scott J.D., Bahouth S.W. AKAP79-mediated targeting of the cyclic AMP-dependent protein kinase to the beta1-adrenergic receptor promotes recycling and functional resensitization of the receptor. J Biol Chem 2006 Nov 3, 281(44):33537-33553.
48. Cong M., Perry S.J., Lin F.T., Fraser I.D., Hu L.A., Chen W., et al. Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem 2001 May 4, 276(18):15192-15199.
49. Bauman A.L., Soughayer J., Nguyen B.T., Willoughby D., Carnegie G.K., Wong W., et al. Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. Mol Cell 2006 Sep 15, 23(6):925-931.
50. Shcherbakova O.G., Hurt C.M., Xiang Y., Dell'Acqua M.L., Zhang Q., Tsien R.W., et al. Organization of beta-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes. J Cell Biol 2007 Feb 12, 176(4):521-533.
51. De Windt L.J., Lim H.W., Bueno O.F., Liang Q., Delling U., Braz J.C., et al. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 2001 Mar 13, 98(6):3322-3327.
52. Gao T., Yatani A., Dell'Acqua M.L., Sako H., Green S.A., Dascal N., et al. cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 1997, 19(1):185-196.
53. Oliveria S.F., Dell'Acqua M.L., Sather W.A. AKAP79/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling. Neuron 2007 Jul 19, 55(2):261-275.
54. Dai S., Hall D.D., Hell J.W. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev 2009 Apr, 89(2):411-452.
55. Navedo M.F., Nieves-Cintron M., Amberg G.C., Yuan C., Votaw V.S., Lederer W.J., et al. AKAP150 is required for stuttering persistent Ca2+ sparklets and angiotensin II-induced hypertension. Circ Res 2008 Feb 1, 102(2):e1-e11.
56. Fraser I.D., Tavalin S.J., Lester L.B., Langeberg L.K., Westphal A.M., Dean R.A., et al. A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J 1998 Apr 15, 17(8):2261-2272.
57. Hulme J.T., Ahn M., Hauschka S.D., Scheuer T., Catterall W.A. A novel leucine zipper targets AKAP15 and PKA to the C-terminus of theskeletal muscle Ca{super2+} channel and modulates its function. J Biol Chem 2001, 30:30.
58. Gray P.C., Johnson B.D., Westenbroek R.E., Hays L.G., Yates J.R., Scheuer T., et al. Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron 1998, 20(5):1017-1026.
59. Fuller M.D., Emrick M.A., Sadilek M., Scheuer T., Catterall W.A. Molecular mechanism of calcium channel regulation in the fight-or-flight response. Sci Signal 2010, 3(141):ra70.
60. Hulme J.T., Lin T.W., Westenbroek R.E., Scheuer T., Catterall W.A. Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15. Proc Natl Acad Sci U S A 2003 Oct 28, 100(22):13093-13098.
61. Lygren B., Carlson C.R., Santamaria K., Lissandron V., McSorley T., Litzenberg J., et al. AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep 2007 Nov, 8(11):1061-1067.
62. Singh A., Redden J.M., Kapiloff M.S., Dodge-Kafka K.L. The large isoforms of A-kinase anchoring protein 18 mediate the phosphorylation of inhibitor-1 by protein kinase A and the inhibition of protein phosphatase 1 activity. Mol Pharmacol 2011 Mar, 79(3):533-540.
63. Nicolaou P., Hajjar R.J., Kranias E.G. Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. J Mol Cell Cardiol 2009 Sep, 47(3):365-371.
64. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295(5554):496-499.
65. Chen L., Marquardt M.L., Tester D.J., Sampson K.J., Ackerman M.J., Kass R.S. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A 2007 Dec 26, 104(52):20990-20995.
66. Terrenoire C., Houslay M.D., Baillie G.S., Kass R.S. The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3. J Biol Chem 2009 Apr 3, 284(14):9140-9146.
67. Piggott L.A., Bauman A.L., Scott J.D., Dessauer C.W. The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc Natl Acad Sci U S A 2008 Sep 16, 105(37):13835-13840.
68. Chen L., Kurokawa J., Kass R.S. Phosphorylation of the A-kinase-anchoring protein Yotiao contributes to protein kinase A regulation of a heart potassium channel. J Biol Chem 2005 Sep 9, 280(36):31347-31352.
69. Sumandea C.A., Garcia-Cazarin M.L., Bozio C.H., Sievert G.A., Balke C.W., Sumandea M.P. Cardiac troponin T, a sarcomeric AKAP, tethers protein kinase A at the myofilaments. J Biol Chem 2011 Jan 7, 286(1):530-541.
70. Russell M.A., Lund L.M., Haber R., McKeegan K., Cianciola N., Bond M. The intermediate filament protein, synemin, is an AKAP in the heart. Arch Biochem Biophys 2006 Dec 15, 456(2):204-215.
71. Sarparanta J., Blandin G., Charton K., Vihola A., Marchand S., Milic A., et al. Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies. J Biol Chem 2010 Sep 24, 285(39):30304-30315.
72. Nakagami H., Kikuchi Y., Katsuya T., Morishita R., Akasaka H., Saitoh S., et al. Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension. Hypertens Res 2007 Dec, 30(12):1239-1246.
73. Mayers C.M., Wadell J., McLean K., Venere M., Malik M., Shibata T., et al. The Rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice. J Biol Chem 2010 Apr 16, 285(16):12344-12354.
74. Appert-Collin A., Cotecchia S., Nenniger-Tosato M., Pedrazzini T., Diviani D. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 2007 Jun 12, 104(24):10140-10145.
75. Carr D.W., Hausken Z.E., Fraser I.D., Stofko-Hahn R.E., Scott J.D. Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain. J Biol Chem 1992, 267(19):13376-13382.
76. Diviani D., Soderling J., Scott J.D. AKAP-Lbc anchors protein kinase A and nucleates galpha 12-selective Rho-mediated stress fiber formation. J Biol Chem 2001 Nov 23, 276(47):44247-44257.
77. Baisamy L., Jurisch N., Diviani D. Leucine zipper-mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc. J Biol Chem 2005 Apr 15, 280(15):15405-15412.
78. Cariolato L., Cavin S., Diviani D. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in alpha1-adrenergic receptor-induced p38 activation. J Biol Chem 2011 Mar 11, 286(10):7925-7937.
79. Jin J., Smith F.D., Stark C., Wells C.D., Fawcett J.P., Kulkarni S., et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004 Aug 24, 14(16):1436-1450.
80. Diviani D., Abuin L., Cotecchia S., Pansier L. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J 2004 Jul 21, 23(14):2811-2820.
81. Carnegie G.K., Soughayer J., Smith F.D., Pedroja B.S., Zhang F., Diviani D., et al. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell 2008 Oct 24, 32(2):169-179.
82. Carnegie G.K., Smith F.D., McConnachie G., Langeberg L.K., Scott J.D. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol Cell 2004 Sep 24, 15(6):889-899.
83. Smith F.D., Langeberg L.K., Cellurale C., Pawson T., Morrison D.K., Davis R.J., et al. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat Cell Biol 2010 Dec, 12(12):1242-1249.
84. Kehat I., Davis J., Tiburcy M., Accornero F., Saba-El-Leil M.K., Maillet M., et al. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ Res 2011 Jan 21, 108(2):176-183.
85. Kapiloff M.S. Contributions of protein kinase A anchoring proteins to compartmentation of cAMP signaling in the heart. Mol Pharmacol 2002 Aug, 62(2):193-199.
86. Bauman A.L., Michel J.J., Henson E., Dodge-Kafka K.L., Kapiloff M.S. The mAKAP signalosome and cardiac myocyte hypertrophy. IUBMB Life 2007 Mar, 59(3):163-169.
87. Dodge K.L., Khouangsathiene S., Kapiloff M.S., Mouton R., Hill E.V., Houslay M.D., et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J 2001 Apr 17, 20(8):1921-1930.
88. Kapiloff M.S., Schillace R.V., Westphal A.M., Scott J.D. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci 1999 Aug, 112(Pt. 16):2725-2736.
89. Pare G.C., Bauman A.L., McHenry M., Michel J.J., Dodge-Kafka K.L., Kapiloff M.S. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci 2005 Dec 1, 118(Pt. 23):5637-5646.
90. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000 May 12, 101(4):365-376.
91. Kapiloff M.S., Jackson N., Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci 2001 Sep, 114(Pt 17):3167-3176.
92. Michel J.J., Townley I.K., Dodge-Kafka K.L., Zhang F., Kapiloff M.S., Scott J.D. Spatial restriction of PDK1 activation cascades by anchoring to mAKAPalpha. Mol Cell 2005 Dec 9, 20(5):661-672.
93. Li J., Negro A., Lopez J., Bauman A.L., Henson E., Dodge-Kafka K., et al. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin. J Mol Cell Cardiol 2010 Feb, 48(2):387-394.
94. Wong W., Goehring A.S., Kapiloff M.S., Langeberg L.K., Scott J.D. mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha. Sci Signal 2008, 1(51):ra18.
95. Faul C., Dhume A., Schecter A.D., Mundel P. Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes. Mol Cell Biol 2007 Dec, 27(23):8215-8227.
96. Schulze D.H., Muqhal M., Lederer W.J., Ruknudin A.M. Sodium/calcium exchanger (NCX1) macromolecular complex. J Biol Chem 2003 Aug 1, 278(31):28849-28855.
97. Sette C., Conti M. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J Biol Chem 1996 Jul 12, 271(28):16526-16534.
98. Dodge-Kafka K.L., Bauman A., Mayer N., Henson E., Heredia L., Ahn J., et al. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3. J Biol Chem 2010 Apr 9, 285(15):11078-11086.
99. Ma W., Trusina A., El-Samad H., Lim W.A., Tang C. Defining network topologies that can achieve biochemical adaptation. Cell 2009 Aug 21, 138(4):760-773.
100. Pare G.C., Easlick J.L., Mislow J.M., McNally E.M., Kapiloff M.S. Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res 2005 Feb 15, 303(2):388-399.
101. Wilkins B.J., De Windt L.J., Bueno O.F., Braz J.C., Glascock B.J., Kimball T.F., et al. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol 2002 Nov, 22(21):7603-7613.
102. Bourajjaj M., Armand A.S., da Costa Martins P.A., Weijts B., van der Nagel R., Heeneman S., et al. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem 2008 Aug 8, 283(32):22295-22303.
103. Bueno O.F., Wilkins B.J., Tymitz K.M., Glascock B.J., Kimball T.F., Lorenz J.N., et al. Impaired cardiac hypertrophic response in calcineurin abeta-deficient mice. Proc Natl Acad Sci U S A 2002 Apr 2, 99(7):4586-4591.
104. Yan L., Vatner D.E., O'Connor J.P., Ivessa A., Ge H., Chen W., et al. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 2007 Jul 27, 130(2):247-258.
105. Puckelwartz M.J., Kessler E.J., Kim G., Dewitt M.M., Zhang Y., Earley J.U., et al. Nesprin-1 mutations in human and murine cardiomyopathy. J Mol Cell Cardiol 2010 Apr, 48(4):600-608.
106. Lehnart S.E., Wehrens X.H., Reiken S., Warrier S., Belevych A.E., Harvey R.D., et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 2005 Oct 7, 123(1):25-35.
107. Moellering R.E., Cornejo M., Davis T.N., Del Bianco C., Aster J.C., Blacklow S.C., et al. Direct inhibition of the NOTCH transcription factor complex. Nature 2009 Nov 12, 462(7270):182-188.
108. Iwami G., Kawabe J., Ebina T., Cannon P.J., Homcy C.J., Ishikawa Y. Regulation of adenylyl cyclase by protein kinase A. J Biol Chem 1995 Jun 26, 270(21):12481-12484.
109. Nicol R.L., Frey N., Pearson G., Cobb M., Richardson J., Olson E.N. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001 Jun 1, 20(11):2757-2767.